Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02736071
Other study ID # Hyst 8
Secondary ID
Status Recruiting
Phase Phase 3
First received April 8, 2016
Last updated July 3, 2016
Start date June 2016

Study information

Verified date July 2016
Source Cairo University
Contact AbdelGany M Hassan, MRCOG, MD
Phone +201017801604
Email abdelgany2@gmail.com
Is FDA regulated No
Health authority Egypt: Ministry of Higher Education
Study type Interventional

Clinical Trial Summary

Two hundred and ten women undergoing operative hysteroscopy will be randomly divided into three equal groups. To ensure blinding the double dummy technique will be used in which group 1 will receive Tramadol 100mg orally in addition to a placebo similar to Celecoxib, group 2 will receive Celecoxib 200mg in addition to a placebo similar to Tramadol, and group 3 will received a placebo similar to Tramadol in addition to a placebo similar to Celecoxib. All the drugs will be given 2 hour before the procedure. An independent person will generate the allocation sequence using computer generated random numbers.

Patient's perception of pain will be assessed for each group during the procedure, immediately after and 30 min after the procedure with the use of visual analogue scale (VAS).


Description:

Two hundred and ten women undergoing operative hysteroscopy will be randomly divided into three equal groups. To ensure blinding the double dummy technique will be used in which group 1 will receive Tramadol 100mg orally in addition to a placebo similar to Celecoxib, group 2 will receive Celecoxib 200mg in addition to a placebo similar to Tramadol, and group 3 will received a placebo similar to Tramadol in addition to a placebo similar to Celecoxib. All the drugs will be given 2 hour before the procedure. An independent person will generate the allocation sequence using computer generated random numbers.

All procedures will be scheduled to be done postmenstrual or after cessation of bleeding in case of metrorrhagia and will be done in the lithotomy position. The procedures will be performed using 30 degree angle 2.7 mm rigid hysteroscope with a 5mm outer diameter continuous flow hysteroscope with a 5 French working channel, a Teknolight 180 XA light source, and a Xenon high density fibre optic light cable 3.5mm, 2300mm Light cable without adaptors and a T Camera teknocam 2000S pro. All the equipment are provided by Tekno GmbH and Co®, Germany.

Vaginoscopic approach will be used for insertion of the hysteroscope in all cases. The hysteroscope will be gently introduced into the uterine cavity after visualization of the cervix and identification of the external os. Patient's perception of pain will be assessed for each group during the procedure, immediately after and 30 min after the procedure with the use of visual analogue scale (VAS). VAS of 0 indicates no pain and VAS of 10 indicates the worst possible experienced pain. Patients will also be asked to report any side effects. The main outcome measure will be patients' pain perception during the procedure.

Statistics:

Quantitative data will be statistically represented in terms of mean ± standard deviation (± SD) while categorical data will be represented as frequency and percentage. Comparison of quantitative data will be done using ANOVA test for independent samples while categorical data will be compared using Chi squared test or Fisher exact test when appropriate. A probability value (p value) less than 0.05 will be considered significant.

Sample size calculation:

To the best of researchers knowledge this is the first trial to investigate the role of Celecoxib and oral Tramadol in reducing outpatient operative hysteroscopy associated pain, with no previous data to calculate the sample size with. Data from studies on diagnostic hysteroscopy cannot be applied because operative hysteroscopies need more manipulations and cause more pain. Assuming that the response will be normally distributed, the sample size is calculated to detect a mean difference of 1 unit between Tramadol and Celecoxib pain scores during the procedure (lower difference are not considered clinically relevant) using VAS assuming that the within group standard deviation will be 2. Investigators will need to study 64 cases in each group to be able to reject the null hypothesis that the population means of the Tramadol and Celecoxib are equal with probability (power) 0.8. Investigators added 6 cases to each arm accounting for any missing data and procedure failure ending in 70 cases in each group. The Type I error probability associated with this test of this null hypothesis is 0.05 using Student's t test for independent samples. Sample size calculation is done using Stats Direct statistical software version 2.7.2 for microsoft Windows, Stats Direct Ltd., Cheshire, UK.


Recruitment information / eligibility

Status Recruiting
Enrollment 210
Est. completion date
Est. primary completion date April 2017
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 45 Years
Eligibility Inclusion Criteria:

- Indication for operative outpatient hysteroscopy, indications will include endometrial biopsy, polypectomy, septum resection, intra-uterine device removal and adhesiolysis.

Exclusion Criteria:

- Submucous myomas.

- Known medical disorders like uncontrolled diabetes, hypertension, cardiac, renal or liver disease.

- Gastritis or peptic ulcer.

- Allergy to Tramadol or Celecoxib.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Drug:
Celecoxib
Women will receive oral Celecoxib 200mg 2 hours before the procedure
Tramadol
Women will receive oral Tramadol 100mg 2 hours before the procedure
Placebo 1
Women will receive an oral placebo similar to Tramadol 2 hours before the procedure
Placebo 2
Women will receive an oral placebo similar to Celecoxib 2 hours before the procedure

Locations

Country Name City State
Egypt Cairo University Hospitals Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

References & Publications (3)

Ahmad G, Attarbashi S, O'Flynn H, Watson AJ. Pain relief in office gynaecology: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2011 Mar;155(1):3-13. doi: 10.1016/j.ejogrb.2010.11.018. Epub 2011 Jan 20. Review. — View Citation

Hassan A, Wahba A, Haggag H. Tramadol versus Celecoxib for reducing pain associated with outpatient hysteroscopy: a randomized double-blind placebo-controlled trial. Hum Reprod. 2016 Jan;31(1):60-6. doi: 10.1093/humrep/dev291. Epub 2015 Nov 29. — View Citation

van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG. 2007 Jun;114(6):664-75. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain perception during the procedure A nurse will hand the patient a VAS and the patient will mark the point corresponding to her pain 5 minutes after starting the procedure No
Secondary Pain perception after the procedure A nurse will hand the patient a VAS and the patient will mark the point corresponding to her pain 30 minutes after completing the procedure No
See also
  Status Clinical Trial Phase
Completed NCT05514236 - Effect of Virtual Reality and Music Therapy on Pain Relief in Outpatient Hysteroscopy N/A
Completed NCT06092541 - Pericervical Analgesia Versus Analesia With Nitrous Oxide (N2O) in Outpatien Operative Hysteroscopy With Miniresector N/A
Not yet recruiting NCT05069077 - the Effect of Music on Pain and Women Satisfaction During Diagnostic Outpatient Hysteroscopy in Postmenopausal Women N/A
Completed NCT03701984 - The Effect of Intrauterine Lidocaine Infusion and Oral Tramadol on Pain During Diagnostic Office Hysteroscopy Phase 4
Not yet recruiting NCT05069025 - Use of Music in Reducing Pain During Outpatient Hysteroscopy in Primarily Infertile Patients N/A
Completed NCT04166500 - Early Outpatient Hysteroscopy Can Prevent Intrauterine Adhesion After Induced Abortion N/A
Not yet recruiting NCT06379841 - Green Hysteroscopy N/A
Completed NCT02863679 - Postoperative Analgesic Efficacy of Tetracaine Hydrochloride Gel N/A
Completed NCT02142686 - Comparison Between Different Filling Pressures in Diagnostic Outpatient Hysteroscopy N/A
Completed NCT02142673 - The Impact of Different Filling Pressures in Operative Outpatient Hysteroscopy on the Procedure Success Rates and Associated Pain. N/A
Completed NCT05540379 - Role of Virtual Reality Simulators in Basic Hysteroscopy Training Competence N/A
Completed NCT04462835 - Feasibility, Effectiveness and Safety of Outpatient Hysteroscopy
Recruiting NCT04862598 - Virtual Reality to Improve Satisfaction in Hysteroscopy Patients N/A
Recruiting NCT01376934 - Clinical Trial of Hysteroscopy in Postmenopausal Women to Compare Techniques N/A
Not yet recruiting NCT06172140 - Efficacy and Safety of Ciprofol for the Sedation in Patients Undergoing Hysteroscopy N/A
Recruiting NCT03409835 - Effect of Ramosetron on Post-discharge Nausea and Vomiting N/A
Enrolling by invitation NCT03579550 - Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus N/A
Recruiting NCT02736019 - Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal Women Phase 3
Not yet recruiting NCT05858931 - Hysteroscopic Evaluation and the Clinical Outcomes of Vaginal Repair of Cesarean Section Scar Defects
Completed NCT04232930 - The Use of Music in Reducing Pain During Outpatient Hysteroscopy N/A